http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102457866-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate | 2020-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102457866-B1 |
| titleOfInvention | New inhibitors for the metallo-beta-lactamase produced by a multi-resistant bacteria and methods of preparation thereof |
| abstract | The present invention relates to a novel metallo-beta-lactamase (MBL) inhibitor and a multidrug-resistant antimicrobial composition comprising the same, and is a compound of Formula 1 or a derivative thereof. Formula 1 where R 1 is or to be. The MBL inhibitor of Formula 1 according to the present invention has inhibitory activity against MBL of a broad spectrum. It is useful for preventing and treating infections caused by multidrug-resistant bacteria because it can prevent decomposition and extend the action time and range of antibiotics, and can also kill bacteria that can acquire resistance to antibiotics due to the presence of MBL do. |
| priorityDate | 2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.